USPTO serial 79439212
PEAK PERFORMANCE INNOVA
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALBANO, ASHLEY C
- Law office
- TMEG LAW OFFICE 105
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PEAK PERFORMANCE INNOVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aurora Lambert
Aurora Lambert US Trademarks418 Broadway, Ste. YAlbany, NY 12207United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Test paper, chemical; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; biochemical catalysts; diagnostic preparations for research laboratory use; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes. | ACTIVE | — |
| 005 | Medicines for the treatment of tumors, autoimmune diseases, inflammatory disorders, metabolic disorders, cardiovascular diseases, neurological disorders, rare ocular, respiratory, gastrointestinal diseases, skin disorders, respiratory diseases, blood disorders for human purposes; chemico-pharmaceutical preparations for the treatment of tumors, autoimmune diseases, inflammatory disorders, metabolic disorders, cardiovascular diseases, neurological disorders, rare ocular, respiratory, gastrointestinal diseases, skin disorders, respiratory diseases, blood disorders; drugs being pharmaceutical preparations for the treatment of tumors, autoimmune diseases, inflammatory disorders, metabolic disorders, cardiovascular diseases, neurological disorders, rare ocular, respiratory, gastrointestinal diseases, skin disorders, respiratory diseases, blood disorders for medical purposes; pharmaceutical preparations for the treatment of tumors, autoimmune diseases, inflammatory disorders, metabolic disorders, cardiovascular diseases, neurological disorders, rare ocular, respiratory, gastrointestinal diseases, skin disorders, respiratory diseases, blood disorders; biological and chemical drugs being pharmaceutical preparations for the treatment of tumors, autoimmune diseases, inflammatory disorders, metabolic disorders, cardiovascular diseases, neurological disorders, rare ocular, respiratory, gastrointestinal diseases, skin disorders, respiratory diseases, blood disorders; chemical preparations for pharmaceutical purposes, namely, for treatment of tumors, autoimmune diseases, inflammatory disorders, metabolic disorders, cardiovascular diseases, neurological disorders, rare ocular, respiratory, gastrointestinal diseases, skin disorders, respiratory diseases, blood disorders; syrups for pharmaceutical purposes for the treatment of tumors, autoimmune diseases, inflammatory disorders, metabolic disorders, cardiovascular diseases, neurological disorders, rare ocular, respiratory, gastrointestinal diseases, skin disorders, respiratory diseases, blood disorders; capsules sold empty for medicines. | ACTIVE | — |
| 010 | Medical apparatus and instruments for use in the procedure of surgery, diagnosis, treatment; syringes for medical purposes; apparatus for administering inhalants for medical purposes; dental apparatus and instruments; electric facial aesthetic treatment apparatus, other than facial steamers; pill crushers; babies' bottles; condoms; surgical implants comprised of artificial materials. | ACTIVE | — |
| 035 | Advertising; commercial information agency services; business management consultancy; business management assistance; business appraisals; commercial and industrial management assistance; retail and wholesale store services featuring medical supplies; retail and wholesale store services featuring hygienic preparations; pharmaceutical retail and wholesale store services, namely, online and offline retail and wholesale distribution services for pharmaceuticals; providing pharmaceutical retail pharmacy and wholesale distribution services through physical stores, e-commerce platforms, and online ordering channels; retail and wholesale store services featuring pharmaceutical preparations. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PEAK PERFORM INNOVA (SUZHOU) CO., LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Similar marks named PEAK PERFORMANCE INNOVA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 27, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 27, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 25, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 24, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2026 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Feb 18, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 17, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 15, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 11, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |